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A comparison was made of fl-endorphin (B-END) concentrations versus post-translation products during the perinatal period in the hy- 
pothalamus and the caudal medulla oblongata. The concentration of B-END-like immunoreactivity did not differ statistically between em- 
bryonic day 21 (E21) and postnatal day 1 (P1) in either area. There were significant differences in forms, with a shift from larger precursors 
at E21 to smaller peptides at P1, with the predominant form of B-END being the 31 residue form at E21 in both regions. B-END varied 
between the two regions at P1, the 27-26 residue predominant in the hypothalamus, and the 31 residue in the caudal medulla. 
INTRODUCTION 
Pro-opiomelanocortin (POMC) and its post-transla- 
tional products, e.g. fl-lipotropin (B-LPH) fl-endorphin 
(B-END), adrenocorticotropin (ACTH), and a-melano- 
cyte-stimulating hormone (a-MSH) have been identified 
in perikarya of the arcuate nucleus of the hypothalamus, 
the nucleus tractus solitarii of the caudal medulla oblon- 
gata and the anterior and intermediate lobes of the pi- 
tuitary in the rat during postnatal development and 
adulthood 1-3'8'14'15A7'18'23. The first appearance of 
POMC in hypothalamic neurons occurs on embryonic 
day 12 and in the perikarya of the nucleus tractus soli- 
tarii on embryonic day 1712"13. In the pituitary, POMC 
appears in the anterior lobe on embryonic day 15 and in 
the intermediate lobe on embryonic day 1612. Radioim- 
munoassay studies of the nucleus tractus solitarii have 
demonstrated B-END-like immunoreactivity increases 
steadily from postnatal day 1 to postnatal day 42 and 
becomes comparable to adult levels 2. Post-translational 
processing of B-END has been examined during devel- 
opment only in the pituitary 25"26. Opioid activity of 
B-END can be significantly reduced through C-terminal 
cleavage as well as acetylation 7'2°'29. Seizenger 26 found 
that in the neurointermediate lobe of the newborn rat 
the predominant form of B-END was 31-residue peptide 
in the acetylated form similar to the adult. The interme- 
diate lobe also demonstrated decreased proteolysis of 
the B-END C-terminal. The anterior lobe demonstrated 
processing in the newborn similar to the adult with a 
higher proportion of the B-END-immunoreactive mate- 
rial in the larger forms and less acetylation of the B-END 
peptides. Sato 25 found that in the neurointermediate 
lobe of the neonate rat the rate of C-terminal shorten- 
ing was less than that found at postnatal day 21 and the 
adult age rat. 
In human studies, the level of B-END immunoreac- 
tivity has been measured in the brainstem and the cer- 
ebellum of victims of Sudden Infant Death Syndrome TM 
22. The B-END immunoreacticity was found to be higher 
in the brainstem of victims of Sudden Infant Death Syn- 
drome than in the control population. The depressant 
effect of opioids on respiration is a classic response. 
Moss found with injection of B-END into the cerebral 
spinal fluid of lightly anesthetized dogs there was a pe- 
riod of hypoventilation followed by hypotension and brady- 
cardia 19. Increased respiratory function with the infusion 
of an opioid antagonist, naloxone, has been demon- 
strated in newborn rabbits H. The question which devel- 
ops from these studies is whether or not the B-END 
peptides formed in the POMC perikarya of the caudal 
medulla oblongata and the hypothalamus undergo post- 
translational processing at the time of parturition alter- 
ing the peptide's opioid activity and its effect on respi- 
ration. 
In the following study, we determine if the levels of 
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B - E N D  in the  cauda l  medu l l a  ob longa ta  and  hypotha l -  
amus  change  in  accordance  with bir th  an d  how these 
levels compa re  with the adult .  In  addi t ion  to pep t ide  
levels,  the  molecu la r  forms of B - E N D - i m m u n o r e a c t i v e  
pept ides  were  e x a m i n e d  to d e t e rmi n e  the changes  in 
pos t - t rans la t iona l  processing.  
MATERIALS AND METHODS 
Tissue preparation 
The rats selected for the study were of the Sprague-Dawley va- 
riety (Charles Rivers, Portland, MI). Paired adult male and virgin 
female rats were maintained in a 12-h light and 12-h dark schedule 
with food and water ad libitum. The female rats were examined 
daily for fertilization by vaginal saline lavage. Females with sperm 
present in the lavage were placed in individual cages. The date of 
conception, embryonic day 0, was based on the first appearance of 
sperm. The embryonic day 21 rats were excised in utero and placed 
in iced saline until the time of decapitation. The postnatal day 1 
rats were maintained with their mother for one day after birth prior 
to being sacrificed. The adult males used for tissue sampling were 
not used to fertilize females and were maintained in separate cages. 
All embryonic day 21, postnatal day 1 and adult rats were sacri- 
riced by decapitation. The hypothalamie tissue containing the ar- 
cuate nucleus was dissected as a block of tissue as described by 
Glowinski 9. Anatomical margins for dissection of the nucleus trae- 
tus solitarii from within the medulla oblongata consisted of the 
obex as the rostral boundary and the medulla-cord junction as the 
caudal boundary. The dissected tissue was placed on dry ice and 
stored at -80 °C prior to preparation for assay. Tissue extraction 
was performed as previously described 3. 
Radioimmunoassay of fl-endorphin 
The B-END radioimmunoassay (RIA) procedure was performed 
as previously described 6. The assay consisted of a 3-day diseqnifib- 
rium procedure using 4% sheep-anti-rabbit globulin serum as the 
second antibody. The peptide used as the standard and for iodina- 
tion was human B-END (1-31) (Cat. No. 8616, Peninsula Lab, 
Belmont, CA). The antiserum was donated by Dr. Hnda Akil 
(Mental Health Research Institute, University of Michigan). The 
ICs0 for the assay was 8.6 -+ 0.7 fmol per tube and the sensitivity 
was 4.0 -+ 0.3 fmol per tube. The interassay coefficient of variation 
was 7.5% and the intraassay coefficient of variation was 6.8%. 
The BIEND antiserum is 100% cross-reactivity with its larger 
molecular weight precursors, POMC and fl-lipotropin. The antise- 
rum showed no cross-reactivity with 7-endorphin [B-END(I-16)], 
ACTH, a-MSH, 7-MSH, Leu- or Met-enkephelin, dynorphin-re- 
lated peptides or a number of non-opioid pituitary peptides. A 
complete characterization of the antiserum can he found in Cab.ill 
et all 6. The B-END-like immunoreactivity measured in the RIA 
was the sum total of B-END, fl-lipotropin and POMC immunore- 
activities. 
Individual timepoint measurements 
The measurements of B-END levels at embryonic day 21, post- 
natal day 1 and adult were expressed as the mean - the standard 
error of the mean for 5 animals. The protein concentration of tis- 
sue samples was determined by a Folin phenol reagent procedure 
as described by Lowry 16. 
Chromatography 
A 1.5 x 90 cm column was prepared with G-50 superfine 
sepharose gel (Cat. No. G50-50, Sigma Chemical Co., St. Louis, 
MO). The eluent buffer was 10% formic acid, 0.1% BSA, and 0.1% 
2-mercaptoethanol. A 2-mg sample of bovine serum albumin and 
50-~1 sample of 2-mercaptoethanol were added to the chromato- 
graphic samples to detect the V o and V t, respectively, by means of 
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Fig. 1. The concentration of B-END-like immunoreactivity per mg 
protein for caudal medulla oblongata and hypothalamus. Results 
are expressed as the mean + S.E.M. for 5 animals per time point. 
The inset demonstrates alterations in the levels of the B-END-like 
immunoreactivity for embryonic day 21 and postnatal day 1. The 
units are expressed as concentration in femtomoles of immunore- 
activity per mg protein. CMO, caudal medulla oblongata; HYPO, 
hypothalamus; E21, embryonic day 21; P1, postnatal day 1; A. 
adult; B-END, fl-endorphin. 
hour, with 1.1 ml per fraction. The collected samples were lyo- 
philized and stored at -80 °C. At the time of the assay, the sam- 
ples were resuspended in 1 ml of 1% formic acid. The number of 
regions pooled for the sample for embryonic day 21 was 55 for the 
caudal medulla oblongata and 60 for the hypothalamus. The num- 
ber of regions pooled for the hypothalamus and for the caudal me- 
dulla oblongata for postnatal day 1 was 65 and the adult was 15. 
The identification of the immunoreactive peaks was performed by 
comparison with known standards using B'LPH which was donated 
by Dr. C.H. Li (Department of Psychiatry at the University of 
California San Francisco) and B,END (1,31), (1-27), (1-26) (Pen- 
insula Laboratories). The POMC peak was determined by identi- 
fying the immunoreactive peak with the shortest retention time 
since this peptide is the highest molecular weight peptide that is 
immtmoreactive to the B-END radioimmunoassay. 
Statistical analysis 
The statistical analysis on the individual timepoint B-END levels 
of immunoreactivity was performed using single factor ANOVA 
and post-hoe analysis. The level of significance was a = 0.05. The 
ratios of immtmoreactive peptides were calculated using the 
summed immunoreactivities of the fractions. 
RESULTS 
B - E N D  levels 
The  values  ( m e a n  -+ S . E . M . )  for B - E N D - l i k e  i m m u -  
noreac t iv i ty  pe r  mi l l igram pro te in  in  the  cauda l  medu l l a  
ob longa t a  was 14.1 - 3.0 fmol /mg p ro t e in  for e m b r y o n i c  
day 21, 12.9 - 5.4 fmol /mg p ro te in  for pos tna ta l  day 1 
and  141.5 --- 6.1 fmol /mg p ro t e in  for  the adul t .  The re  
was no  statistical d i f ference  b e t w e e n  e m b r y o n i c  day  21 
and  pos tna ta l  day 1; however ,  pos tna ta l  day  1 was sta- 
tistically di f ferent  f rom the  adul t  ( P  < 0.003) as was 
e m b r y o n i c  day  21 f rom adul t  ( P  < 0.04). 
The  values  for the  concen t r a t i on  of  B - E N D  in the hy- 
po tha l amus  as depic ted  in  Fig. 1 were  17.5 - 1.6 fmol /mg 
pro te in  for e m b r y o n i c  day  21, 21.6 --+ 3.6 fmol /mg pro-  
tein for postnatal day 1 and 768.5 + 50,9 fmol/mg pro- 
tein for the adult. There was no statistical difference be- 
tween embryonic day 21 and postnatal day 1 for the 
hypothalamus; however, there was a statistical difference 
between embryonic day 21 and adult (P < 0.01) as well 
as postnatal day 1 and adult (P < 0.02). 
Chromatography 
Fig. 2 represents the patterns of B-END-like immu- 
noreactive material separated by molecular exclusion 
chromatography for ages embryonic day 21, postnatal 
day 1 and adult. Percentages of peak immunoreactivity 
for the peptides were calculated based on total immu- 
noreactivity found by radioimmunoassay of the chro- 
matographic fractions. The total sum of immunoreactive 
peaks found during chromatographic separation of the 
pooled caudal medulla oblongata regions were 599.5 
fmol for embryonic day 21, 1452.2 fmol for postnatal day 
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Fig. 2. The chromatographic patterns of B-END-like immunoreactive material for the caudal medulla oblongata and hypothalamus for in- 
dividual time point pooled tissue samples from embryonic day 21, postnatal day 1 and adult. Aliquots from extracts of 55 embryonic days 21 
nucleus tractus solitarii, 60 embryonic day 21 hypothalamus, 65 postnatal day 1 for nucleus tractus solitarii and hypothalamus and 15 adult 
nucleus tractus solitarii and hypothalamus were separated on Sephadex G50-50 superfine 15 x 900 mm column with 1.1 ml per fraction and 
assayed for B-END, For further details see Material and Methods. Void volume was determined with bovine serum albumin and total vol- 
ume with 2-mercaptoethanol. 
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TABLE I 
The ratios of the immunoreactivity calculated for the B-END 3l- 
residue and the 27,26-residue peptides in the hypothalamus and 
caudal medulla oblongata at embryonic day 21, postnatal day 1 
and adult 
The chromatographic peak of the 27-residue B-END peptide 
overlapped the 26-residue peptide peak, so the immunoreactivi- 
ties were combined to calculate the ratios. 
Age Medulla Hypothalamus 
B-END B-END B-END B-END 
(1-31) (1-27,26) (1-31) (1-27,26) 
Embryonic day 21 4.48 l 2.11 1 
Postnatal day 1 1.79 1 1 1.90 
Adult 2.19 1 1 1.06 
1 and 2154.5 fmol for adult tissue pools. For the caudal 
medulla oblongata tissue, the percentage of POMC im- 
munoreactivity decreased across the 3 time points with a 
value of 12.4% (74.5 fmol/peak) for embryonic day 21 
to 1.6% (23.3 fmol/peak) for postnatal day 1. No immu- 
noreactivity could be assayed in the fractions in the vi- 
cinity of the expected POMC peak for the adult tissue. 
The percentage of B-LPH rose from 9.0% (54.0 fmol/ 
peak) for embryonic day 21 to 15.6% (226.1 fmol/peak) 
for postnatal day 1. B-LPH could not be detected in the 
vicinity of similar fractions for the adult tissue. The per- 
centage of the total B-END immunoreactivity, i.e. both 
the 31- and 27,26-residue peptides was 78.6% (471.0 
fmol/peak) for embryonic day 21, 82.8% (1202.8 fmol/ 
peak) for postnatal day 1 and 100% (2154.8 fmol/peak) 
for the adult. 
The total immunoreactivity for the sum of the peaks 
measured in the pooled hypothalamic chromatographic 
samples was 3036.7 fmol for embryonic day 21, 6454.4 
fmol for postnatal day 21, and 27,764.9 fmol for the 
adult. The hypothalamic POMC peak percentages de- 
creased more rapidly than the nucleus tractus solitarii 
with embryonic day 21 at 5.5% (165.6 frnol/peak) and 0% 
for both postnatal day 1 and adult. The percentage of 
hypothalamic B-LPH for embryonic day 21 was 3.5% 
(105.6 fmol/peak), postnatal day 1 was 3.4% (217.8 fmol/ 
peak) and 0% in the adult. The peak percentage for the 
total B-END in the hypothalamus was 91.0% (2765.6 
fmol/peak) at embryonic day 21, 96.6% (6236.7 fmol/ 
peak) for postnatal day 1 and 100% for the adult. 
DISCUSSION 
The results indicate that the relative concentration of 
B-END-like immunoreaetivity does not fluctuate signif- 
icantly between embryonic day 21 and postnatal day 1 
in the caudal medulla oblongata and the hypothalamus. 
An alteration did occur in the post-translational process- 
ing of the POMC and related peptides, demonstrated by 
a shift in the pattern of processing from a high molecu- 
lar weight precursor to intermediate and low molecular 
weight peptides for both the caudal medulla oblongata 
and the hypothalamus between embryonic day 21 and 
postnatal day 1. The difference in the rate of post-trans- 
lational processing of POMC between the caudal me- 
dulla oblongata and the hypothalamus may occur either 
as a result of an immature enzymatic proteolysis system 
or immunoreactive material originating from another 
source. The caudal medulla oblongata may not contain 
as high a concentration of proteolytic enzymes or the 
enzymes may not be activated to the same extent as 
found in the hypothalamus. The potential for material 
originating from other sites has been demonstrated by 
Alessi and Quinlan 4, Van der Kooy 28 and Gray l°. Alessi 
demonstrated in monosodium glutamate (MSG)-treated 
rats that there was a significant drop in the concentra- 
tion of B-END-like immunoreactivity in the ventral sec- 
tion of the caudal medulla oblongata while the dorsal 
section did not statistically differ from saline control an- 
imals. No immunocytochemical changes were found in 
the nucleus tractus solitarii between the saline and MSG- 
treated animals. The existence of a route for transport 
of peptides into the caudal medulla oblongata was dem- 
onstrated by Van der Kooy. In this study, retrograde 
track tracing revealed projections from cell bodies in the 
hypothalamus to the medulla oblongata 2~. Gray, utiliz- 
ing combined fluorescent retrograde tracer and immuno- 
fluorescence techniques, located axons from POMC cells 
in the lateral arcuate regions of the hypothalamus ex- 
tending to the nucleus tractus solitarii-dorsal vagal com- 
plex 1°. In our study the caudal medulla oblongata was 
not subdivided into ventral and dorsal sections and POMC 
peptides in the tissue may have originated from another 
site. 
The cleavage of the 31-residue B-END peptide dif- 
fered between the caudal medulla oblongata and hypo- 
thalamus. For the caudal medulla oblongata, the de- 
crease in the ratio of the immunoreactivity of 31-residue 
peak to the 27,26-residue peak between embryonic day 
21 and postnatal 1 may be due to either an increase in 
proteolytic enzyme activity or an increased concentration 
of the immunoreactive material originating from 
perikarya outside the dissected region. The hypothala- 
mus had a more dramatic shift in the ratios between 
embryonic day 21 and postnatal day 1. The 31-residue 
peptide immunoreactivity predominated at greater than 
a 2 to 1 ratio at embryonic day 21 while at postnatal day 
1 the 27,26-residue immunoreactivity predominated at a 
ratio nearly 2 to 1. Smyth 27 and Bleakrnan 5 have dem- 
onstrated that proteolytic processing of POMC occurs in 
a sequential  fashion, therefore no C-terminal  proteolytic 
processing occurs on the B-LPH peptide. The formation 
of the 27, and 26-residue B-END peptides is from the 
31-residue peptide. The dramatic ratio shifts in the hy- 
pothalamus appear to be activation of the C-terminal 
proteolysis system occurring at the time of parturit ion.  
In the case of the caudal medulla oblongata,  the ratio 
simply decreases between the 31-residue and 27,26-resi- 
due peptides. 
In conclusion, the tissue levels and concentrat ion of 
B-END are relatively consistent prior to and following 
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